Cite
HARVARD Citation
Kim, N. et al. (2020). Colorectal adenocarcinoma‐derived EGFR mutants are oncogenic and sensitive to EGFR‐targeted monoclonal antibodies, cetuximab and panitumumab. International journal of cancer. 146 (8), pp. 2194-2200. [Online].